39.80
1.34%
-0.54
시간 외 거래:
39.80
Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스
Jump Financial LLC Buys New Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
MarketBeat
A company insider recently sold 2092 shares of Xenon Pharmaceuticals Inc [XENE]. Should You Sale? – Knox Daily - Knox Daily
Knox Daily
Wedbush Reiterates Xenon Pharmaceuticals (XENE) Outperform Recommendation - MSN
MSN
Did Xenon Pharmaceuticals Inc (XENE) perform well in the last session? – US Post News - US Post News
US Post News
Daily Market Movement: Xenon Pharmaceuticals Inc (XENE) Sees a -0.27 Decrease, Closing at 40.34 – DWinneX - The Dwinnex
The Dwinnex
Natixis Advisors L.P. Sells 731 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Defense World
Swiss National Bank Has $5.70 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Defense World
Xenon Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XENE) - MarketBeat
MarketBeat
Nicholas Investment Partners LP Has $4.04 Million Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
MarketBeat
(XENE) On The My Stocks Page - Stock Traders Daily
Stock Traders Daily
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Reaffirmed by Needham & Company LLC - Defense World
Defense World
Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) PT at $59.11 - MarketBeat
MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Defense World
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade - Defense World
Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade - MarketBeat
MarketBeat
Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 - MarketBeat
MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus - MSN
MSN
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus - Yahoo Finance
Yahoo Finance
Xenon Pharmaceuticals (NASDAQ:XENE) Given Buy Rating at Needham & Company LLC - MarketBeat
MarketBeat
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Financial Post
Financial Post
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire Inc.
Xenon Pharmaceuticals: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Xenon Pharmaceuticals to Highlight Advances at Health Care Conference - TipRanks.com - TipRanks
TipRanks
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 - Financial Post
Financial Post
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 - The Globe and Mail
The Globe and Mail
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
GlobeNewswire Inc.
Xenon Pharmaceuticals (XENE) Set to Announce Earnings on Thursday - Defense World
Defense World
Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Movies Canada
Yahoo Movies Canada
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by TimesSquare Capital Management LLC - MarketBeat
MarketBeat
Xenon Pharmaceuticals Spotlight at Global Healthcare Conference - TipRanks.com - TipRanks
TipRanks
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire Inc.
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock - Zacks Investment Research
Zacks Investment Research
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
Zacks Investment Research
Are You Looking for a Top Momentum Pick? Why Xenon Pharmaceuticals (XENE) is a Great Choice - Yahoo Movies UK
Yahoo Movies UK
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Analysts Just Trimmed Their Revenue Forecasts By 10% - Yahoo New Zealand News
Yahoo New Zealand News
Xenon Pharmaceuticals Unveils Q1 2024 Results - TipRanks.com - TipRanks
TipRanks
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and ... - Financial Post
Financial Post
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire Inc.
Investors Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat
MarketBeat
abrdn plc Takes $1.48 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
MarketBeat
Federated Hermes Inc. Invests $15.96 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Defense World
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - Quantisnow
Quantisnow
Xenon Pharma to Spotlight Innovations at Investor Conference - TipRanks.com - TipRanks
TipRanks
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Investing.com UK
Investing.com UK
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire Inc.
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Investing.com South Africa
Investing.com South Africa
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Xenon Pharmaceuticals is Now Oversold (XENE) - Nasdaq
Nasdaq
자본화:
|
볼륨(24시간):